Atypical Parkinsonian Syndromes: A General Neurologists Perspective
Eur J Neurol 25:41-58, Deutschlander, A.B.,et al, 2018
Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017
Criteria for the Diagnosis of Corticobasal Degeneration
Neurol 80:496-503, Armstrong, M.J.,et al, 2013
Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008
Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Progressive Supranuclear Palsy:Clinical Features & Response to Treatment in 16 Patients
Ann Neurol 13:273-278, Jackson,J.A.,et al, 1983
Subcortical Dementia of Progressive Supranuclear Palsy
JNNP 37:121, Albert,M.,et al, 1974
An 81-Year-Old Man with Imbalance and Memory Impairment
, Golbe,L.I.,et al,
Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020
Degenerative Diseases of the Nervous System, Progressive Supranuclear Palsy
Adams & Victors Principles of Neurology, Chp 39, pg 1096, Ropper, A.H.,et al, 2014
Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008
Zolpidem in Progressive Supranuclear Palsy
NEJM 341:543-544, Daniele,A.,et al, 1999
Pharmacological Therapy in Progressie Supranuclear Palsy
Arch Neurol 55:1099-1102, Kompoliti,K.,et al, 1998
Neuropsychiatric Aspects of Progressive Supranuclear Palsy
Neurol 47:1184-1189, Litvan,I.,et al, 1996
Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995
Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995
Botulinum Toxin-A Improves the Rigidity of Progressive Supranuclear Palsy
Ann Neurol 35:237-239, Polo,K.B.&Jabbari,B., 1994
Progressive Supranuclear Palsy:Neuropathologic and Clinical Heterogeneity
Neurol 44:1015-1024, Gearing,M.,et al, 1994
Idazoxan Treatment in Progressive Supranuclear Palsy
Neurol 41:986-991, Ghika,J.,et al, 1991
Autologous Adrenal Medullary Transplant in Progressive Supranuclear Palsy
Neurol 39:1066-1068, Koller,W.C.,et al, 1989
The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986
Atypical Presentation of Progressive Supranuclear Palsy
Ann Neurol 17:334-343, Davis,P.H.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
Progressive Supranuclear Palsy:Functional Analysis of the Response to Methysergide & Antiparkinsonian Agents
Neurol 31:1507-1518, Rafal,R.D.,et al, 1981
Progressive Supranuclear Palsy:A Clinical, Pathological & Biochemical Study
Neurol 22:445, Antunes,J.L.,et al, 1972